Feasibility of high-dose paclitaxel in the conditioning regimen for autologous hematopoietic transplantation.

被引：0
|
作者：
Perez-Calvo, J
Fernández-Hidalgo, O
Aramendía, JM
Rebollo, J
Salgado, E
Rifón, JJ
Prósper, F
Rocha, E
Martín-Algarra, S
机构：
[1] Univ Navarra Clin, Pamplona, Spain
[2] Clin San Miguel, Pamplona, Spain
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5453
引用
收藏
页码：431B / 431B
页数：1
相关论文
共 50 条
  • [41] Continuous High-Dose Idarubicin and Busulfan As Conditioning Regimen for Chinese Patients with Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation
    Ming, Hong
    Qian, Sixuan
    Peng, Liu
    Wu Hanxin
    Qiu Hongxia
    Hua, Lu
    Zhang Sujiang
    Wei, Xu
    BLOOD, 2012, 120 (21)
  • [42] High-dose etoposide, cytarabine and melphalan as conditioning regimen for autologous stem cell transplantation in patients with refractory or relapsed Hodgkin's lymphoma
    Bekadja, M. A.
    Osmani, S.
    Brahimi, M.
    Talhi, S.
    Bekadja, S.
    Belkhodja, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S446 - S446
  • [43] BORTEZOMIB AND HIGH-DOSE MELPHALAN AS A NOVEL CONDITIONING REGIMEN FOR PATIENTS WITH POEMS SYNDROME UNDERGOING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
    Tang, X.
    Shi, X.
    Hu, X.
    Xue, S.
    Qiu, H.
    Han, Y.
    Yan, L.
    Zhou, H.
    Liu, Y.
    Gu, B.
    Sun, A.
    Wu, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S202 - S202
  • [44] BORTEZOMIB AND HIGH-DOSE MELPHALAN AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A UNIVERSITARY HOSPITAL
    de Miguel, D.
    Morales, D.
    San Roman, I.
    Golbano, N.
    Diaz, M.
    Arbeteta, J.
    Herrero, S.
    Subira, D.
    PInedo, B.
    HAEMATOLOGICA, 2012, 97 : 622 - 622
  • [45] Secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Fetscher, S
    Lange, W
    Finke, J
    Bertz, E
    Mertelsmann, R
    BLOOD, 1995, 86 (10) : 3768 - 3768
  • [46] RESULTS OF HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF MEDULLOBLASTOMA
    Gevorgian, A.
    Morozova, E.
    Kazantsev, I.
    Iukhta, T.
    Safonova, S.
    Punanov, Y.
    Afanasyev, B.
    Zheludkova, O.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S275 - S275
  • [47] Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma
    Dahi, Parastoo B.
    Lee, Jasme
    Devlin, Sean M.
    Ruiz, Josel
    Maloy, Molly
    Rondon-Clavo, Carlos
    Petrlik, Erica
    Tamari, Roni
    Shah, Gunjan
    Scordo, Michael
    Matasar, Matthew J.
    Hamlin, Paul A.
    Papadopoulos, Esperanza
    Jakubowski, Ann A.
    Perales, Miguel-Angel
    Moskowitz, Craig H.
    Sauter, Craig S.
    Giralt, Sergio A.
    BLOOD ADVANCES, 2021, 5 (12) : 2608 - 2618
  • [48] High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer
    Tokuda, Y
    Ohta, M
    Okumura, A
    Kuge, S
    Kubota, M
    Tajima, T
    Mitomi, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) : S94 - S99
  • [49] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Gertz, Marie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 343 - 360
  • [50] High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer
    Y. Tokuda
    Masatoshi Ohta
    Akira Okumura
    Soichi Kuge
    Mitsuhiro Kubota
    Tomoo Tajima
    Toshio Mitomi
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S94 - S99
12345